+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Duopa"

Dyskinesia- Pipeline Insight, 2025 - Product Thumbnail Image

Dyskinesia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Lewy Body Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Lewy Body Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Global Parkinson's Disease Drugs Market 2018-2024 - Product Thumbnail Image

Global Parkinson's Disease Drugs Market 2018-2024

  • Report
  • March 2019
  • 110 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Duopa is a type of central nervous system (CNS) drug used to treat symptoms of Parkinson's disease. It is a combination of two drugs, carbidopa and levodopa, which are delivered directly into the small intestine via a pump. The drug is designed to provide a steady, continuous dose of the two drugs, which helps to reduce the "off" periods associated with Parkinson's disease. Duopa is a relatively new drug, having been approved by the U.S. Food and Drug Administration in 2015. Duopa is a part of a larger market of CNS drugs, which includes medications used to treat a variety of neurological conditions, such as Alzheimer's disease, epilepsy, and multiple sclerosis. These drugs are typically used to reduce symptoms, improve quality of life, and slow the progression of the disease. Companies in the Duopa market include AbbVie, Impax Laboratories, and Teva Pharmaceuticals. Show Less Read more